Charles River Laboratories (NYSE:CRL)

CAPS Rating: 4 out of 5

The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.

Recs

3
Player Avatar indyjoneses (99.52) Submitted: 12/28/2006 7:13:34 PM : Outperform Start Price: $43.55 CRL Score: -21.65

Given current trend in Pharma industry to outsource as opposed to hiring, I would expect companies like this that provide specialized and necessary services to Pharma to do well in the long run, regardless of what happens to the stock prices of the pharma sector.

Featured Broker Partners


Advertisement